A Study to Evaluate a Supplement Combination in Supporting Weight Loss, Metabolic Health, and Quality of Life (RESMRESG101)
A Consumer Study to Evaluate the Efficacy of a Postbiotic and Prebiotic Supplement Combination in Supporting Weight Loss, Metabolic Health, and Quality of Life
This consumer-use study evaluates the effects of a combined postbiotic and prebiotic supplement regimen on appetite control, cravings, metabolic health, energy, and quality of life in adults aged 18-65 years with a body mass index (BMI) between 25 and 30.
Participants will consume one capsule of resM™ GLP-1 Postbiotic and one scoop of resG prebeet ENERGY Prebiotic daily for 60 days. Data will be collected through daily check-ins, weekly surveys, and quality-of-life questionnaires administered through the Chloe mobile application.
The primary objective is to evaluate changes in appetite control and food cravings over 60 days of supplementation.
研究概览
详细说明
The GLP-1 Optimizer Bundle combines resM™ GLP-1 Postbiotic and resG prebeet ENERGY Prebiotic to support appetite control, cravings, metabolic health, energy, and lifestyle behaviors.
This is a prospective, open-label, single-arm consumer-use study conducted over 60 days in approximately 20 adults aged 18-65 years with BMI between 25 and 30.
Participants will consume:
one capsule of resM™ GLP-1 Postbiotic daily one scoop of resG prebeet ENERGY Prebiotic daily
Assessments will be collected electronically through the Chloe mobile application and include:
appetite and cravings surveys energy and mood assessments quality-of-life questionnaires lifestyle habit surveys consumer satisfaction assessments
The study aims to evaluate consumer-reported changes associated with daily supplementation and lifestyle guidance.
研究类型
注册 (实际的)
阶段
- 不适用
联系人和位置
学习地点
-
-
Alabama
-
Birmingham、Alabama、美国、35203
- Able Biolabs, LLC
-
-
参与标准
资格标准
适合学习的年龄
- 成人
- 年长者
接受健康志愿者
描述
Inclusion Criteria:
Adults aged 18-65 years BMI between 25 and 30 Generally healthy Willing to comply with study procedures Access to smartphone or internet-enabled device for electronic questionnaires
Exclusion Criteria Pregnant, planning pregnancy, or lactating History of bariatric surgery Prescription weight loss medication use within the past 90 days Current GLP-1 drug use History of substance abuse within the past 6 months Current use of supplements containing overlapping active ingredients Significant medical condition that may interfere with study participation or interpretation of results
学习计划
研究是如何设计的？
设计细节
- 主要用途：其他
- 分配：不适用
- 介入模型：单组作业
- 屏蔽：无（打开标签）
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
实验性的：Active Supplement Bundle
resM™ GLP-1 Postbiotic, and resG prebeet ENERGY Prebiotic
|
Participants will take a combined dosage of prebiotic and postbiotic.
|
研究衡量的是什么？
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Change in Appetite Control and Food Cravings Survey Scores Over 60 Days
大体时间：Baseline through Day 60
|
Participant-reported appetite control and food cravings will be assessed using daily and weekly questionnaires administered through the Chloe mobile application.
Survey responses will evaluate changes in hunger, cravings, satiety, and eating behaviors over the study period.
|
Baseline through Day 60
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Change in Energy and Mood Survey Scores Over 60 Days
大体时间：Baseline through Day 60
|
Participant-reported energy levels and mood will be assessed using weekly questionnaires administered through the participant management application.
|
Baseline through Day 60
|
|
Change in Quality-of-Life Questionnaire Responses Over 60 Days
大体时间：Baseline, Day 30, and Day 60
|
Quality-of-life assessments will evaluate participant-reported physical well-being, lifestyle habits, and overall satisfaction during the study period.
|
Baseline, Day 30, and Day 60
|
|
Participant Satisfaction and Willingness to Continue Product Use at Day 60
大体时间：Day 60
|
End-of-study surveys will assess participant satisfaction, perceived benefits, and willingness to continue using the supplement combination.
|
Day 60
|
合作者和调查者
研究记录日期
研究主要日期
学习开始 (实际的)
初级完成 (实际的)
研究完成 (实际的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
此信息直接从 clinicaltrials.gov 网站检索，没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求，请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改，我们的网站上也会自动更新.